Don't take this disease lightly!

What is HPV ? The most prevalent sexually transmitted infection is human papillomavirus (HPV) (STI). HPV is not the same virus as HIV or HSV (herpes). In 2018, around 43 million people were infected with HPV, the majority of them were in their late teens and early twenties. HPV comes in a variety of shapes and sizes. Some forms, such as genital warts and malignancies, can cause health issues. Vaccines, on the other hand, can prevent certain health concerns from occurring. There are many different forms of HPV, and many of them are harmless. HPV infections normally clear up on their own within a few months of being acquired, and about 90% of them do so within two years. Certain forms of HPV infections can persist and develop to cervical cancer in a tiny percentage of cases. The most common HPV-related illness is cervical cancer. HPV infection is responsible for nearly all occurrences of cervical cancer. Certain HPV varieties also cause malignancies of the anus, vulva, vagina, penis, and oropharynx, which can be prevented by primary preventive techniques similar to those used to prevent cervical cancer. Key points • Human papillomavirus (HPV) is a viral family that is exceedingly common around the world. • There are about 100 different varieties of HPV, at least 14 of which cause cancer (also known as high risk type). • HPV is primarily transmitted through sexual contact, and most people become infected with the virus shortly after sexual activity begins. • Cervical cancer is caused by infection with specific forms of HPV contracted through sexual activity. • 70% of cervical malignancies and pre-cancerous lesions are caused by two HPV types (16 and 18). • HPV has been linked to malignancies of the anus, vulva, vagina, penis, and oropharynx, according to research. • With an estimated 570,000 new cases in 2018, cervical cancer is the fourth most frequent malignancy among women worldwide. LMICs accounted for over 90% of the 311,000 deaths worldwide in 2018. (1). • Primary prevention (HPV vaccine), secondary prevention (screening and treatment of pre-cancerous lesions), tertiary prevention (detection and treatment of invasive cervical cancer), and palliative care are all part of a comprehensive cervical cancer control strategy. • Vaccines against HPV 16 and 18 are recommended by the World Health Organization and have been approved for use in a number of countries. • HPV vaccinations have been found to be safe and effective in preventing HPV infections in clinical trials and post-marketing surveillance. • Cervical cancer can be prevented by screening for and treating pre-cancerous tumors in women. • Cervical cancer can be cured if caught early and treated effectively. How is it spread ? When you have vaginal, anal, or oral sex with someone who has HPV, you can contract the virus. During vaginal or anal sex, it is most usually spread. Even if an infected person shows no signs or symptoms, HPV can still be transmitted. Even if you've only had intercourse with one person, anyone who is sexually active can catch HPV. Symptoms might appear years after having sex with an infected person. It's difficult to tell when you become infected because of this.https://www.painonlinepharma.com/oxycontin-80mg.html How HPV infection leads to cervical cancerhttps://www.painonlinepharma.com/buy-phentermine-15mg-online.html Although most HPV infections and pre-cancerous lesions disappear on their own, there is a risk that HPV infection will become chronic and pre-cancerous lesions may proceed to invasive cervical cancer in all women. Cervical cancer takes 15 to 20 years to develop in women with healthy immune systems. In women with compromised immune systems, such as those with untreated HIV infection, it can take as little as 5 to 10 years. How HPV infection leads to cervical cancer Screening identifies pre-cancerous lesions at an early stage, when they can be easily treated. Cervical cancer is typically not detected until it has progressed and symptoms appear in low and middle-income nations, where access to these prophylactic treatments is limited. Furthermore, access to late-stage cancer treatment (such as cancer surgery, radiotherapy, and chemotherapy) may be limited, resulting in a greater rate of cervical cancer death in these nations. Global effect of cervical cancer https://www.realpharmaneeds.com/buy-oxycontin-40mg-online.html Cervical cancer is the fourth most common malignancy in women worldwide, accounting for 7.5 percent of all female cancer deaths in 2018, with an expected 570 000 new cases. More than 85 percent of the projected 311 000 deaths from cervical cancer each year occur in poor and middle income nations. HIV-positive women are six times more likely than HIV-negative women to develop cervical cancer, with HIV accounting for about 5% of all cervical cancer occurrences (2). In high-income nations, programs exist to ensure that girls are vaccinated against HPV and that women are checked on a regular basis. Screening identifies pre-cancerous lesions at an early stage, when they can be easily treated. Cervical cancer is typically not detected until it has progressed and symptoms appear in low and middle-income nations, where access to these prophylactic treatments is limited. Furthermore, access to late-stage cancer treatment (such as cancer surgery, radiotherapy, and chemotherapy) may be limited, resulting in a greater rate of cervical cancer death in these nations. WHO response ! The World Health Assembly adopted the global strategy to accelerate the elimination of cervical cancer as a public health problem and its associated goals and targets for the period 2020–2030 (WHA 73.2) (4). The global strategy to eliminate cervical cancer has set targets to accelerate the elimination: • a threshold of 4 per 100,000 women-year for elimination as a public health problem • 90–70–90 targets that need to be met by 2030 for countries to be on the path towards cervical cancer elimination • 90% of girls fully vaccinated with the HPV vaccine by age 15. • 70% of women are screened with a high-performance test by 35, and again by 45 years of age. • 90% of women identified with cervical disease receive treatment (90% of women with pre-cancer treated; 90% of women with invasive cancer managed). WHO has developed guidance and tools on how to prevent and control cervical cancer through vaccination, screening and management of invasive cancer and a knowledge repository will make them available through a single point. WHO works with countries and partners to develop and implement comprehensive programmes in line w the global strategy.